| Net Cash Provided by (Used in) Operating Activities |
$22,443,000 |
USD |
-2.9% |
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$7,089,000 |
USD |
99% |
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$5,055,000 |
USD |
-330% |
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
350,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
107,327,691 |
shares |
0.58% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$10,299,000 |
USD |
|
Q1 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,225,150,000 |
USD |
4.6% |
Q3 2024 |
Q3 2024 |
| Depreciation |
$3,626,000 |
USD |
-2.5% |
Q1 2024 |
Q1 2025 |
| Preferred Stock, Shares Issued |
4,915,196 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Outstanding |
4,915,196 |
shares |
0% |
Q4 2024 |
Q3 2025 |
| Current State and Local Tax Expense (Benefit) |
$446,000 |
USD |
298% |
Q3 2024 |
Q3 2024 |
| Current Federal Tax Expense (Benefit) |
$0 |
USD |
-100% |
Q3 2024 |
Q3 2024 |
| Depreciation, Depletion and Amortization |
$16,937,000 |
USD |
-5.3% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |